1. Neuronavigation and surgery of intracerebral tumours

   • P.W.A. Willems
   • J.W. Berkelbach van der Sprenkel
   • M.J.B. Taphoorn

   REVIEW 20 September 2006 Pages: 1123 - 1136

   

2. Apoptotic cascades as possible targets for inhibiting cell death in Huntington’s disease

   • Lindsay R. Pattison
   • Mark R. Kotter
   • Raphael M. Bonelli

   REVIEW 22 September 2006 Pages: 1137 - 1142

   

3. Residual fatigue is independent of antecedent events and disease severity in Guillain-Barré syndrome

   • M.P.J. Garssen
   • R. Van Koningsveld
   • P.A. Van Doorn

   ORIGINAL COMMUNICATION 22 September 2006 Pages: 1143 - 1146

4. Combining short interval MRI in Alzheimer’s disease

   • J.M. Schott
   • C. Frost
   • N. C. Fox

   ORIGINAL COMMUNICATION 22 September 2006 Pages: 1147 - 1153

   

5. Utility of the Mattis dementia rating scale to assess the efficacy of rivastigmine in dementia associated with Parkinson’s disease

   • Kathy Dujardin
   • David Devos
   • Jean-Jacques Péré

   ORIGINAL COMMUNICATION 22 September 2006 Pages: 1154 - 1159

6. Sequential maintenance treatment with glatiramer acetate after mitoxantrone is safe and can limit exposure to immunosuppression in very active, relapsing remitting multiple sclerosis

   • Jason Ramtahal
   • Anu Jacob
   • Mike Boggild

   ORIGINAL COMMUNICATION 21 September 2006 Pages: 1160 - 1164

   

7. Spinocerebellar ataxia type 2 olfactory impairment shows a pattern similar to other major neurodegenerative diseases

   • Luis Velázquez-Pérez
   • Juan Fernandez-Ruiz
   • René Drucker-Colin

   ORIGINAL COMMUNICATION 11 April 2006 Pages: 1165 - 1169

   

8. Cerebrospinal fluid ferritin in chronic hydrocephalus after aneurysmal subarachnoid hemorrhage

   • Hidenori Suzuki
   • Masatoshi Muramatsu
   • Waro Taki

   ORIGINAL COMMUNICATION 28 April 2006 Pages: 1170 - 1176

   

9. CSF protein profiling using Multiplex Immuno-assay

   • Dieta Brandsma
   • Emile E. Voest
   • Martin J.B. Taphoorn

   ORIGINAL COMMUNICATION 22 September 2006 Pages: 1177 - 1184

   

10. Transcranial sonography of the third ventricle and cognitive dysfunction in HIV patients

    • Özgür Yaldizli
    • Oliver Kastrup
    • Matthias Maschke

    ORIGINAL COMMUNICATION 21 September 2006 Pages: 1185 - 1188

    

11. Simple versus complex assessment of white matter hyperintensities in relation to physical performance and cognition: the LADIS study

    • A.A. Gouw
    • W.M. Van der Flier
    • Ph. Scheltens

    ORIGINAL COMMUNICATION 22 September 2006 Pages: 1189 - 1196

    

12. Dural sinus thrombosis in spontaneous intracranial hypotension

    • Mario Savoiardo
    • Silvia Armenise
    • Luisa Chiapparini

    ORIGINAL COMMUNICATION 06 May 2006 Pages: 1197 - 1202

    

13. Contrast sensitivity, first-order motion and Initial ocular following in demyelinating optic neuropathy

    • Janet C. Rucker
    • Boris M. Sheliga
    • R. John Leigh

    ORIGINAL COMMUNICATION 28 April 2006 Pages: 1203 - 1209

    

14. Multiple sclerosis in Jordan: a clinical and epidemiological study

    • Khalid El-Salem
    • Ehsan Al-Shimmery
    • Yousef Khader

    ORIGINAL COMMUNICATION 28 April 2006 Pages: 1210 - 1216

    

15. Interobserver agreement and predictive value for outcome of two rating scales for the amount of extravasated blood after aneurysmal subarachnoid haemorrhage

    • Anouk G.W. van Norden
    • Gert W. van Dijk
    • Gabriël J.E. Rinkel

    ORIGINAL COMMUNICATION 22 September 2006 Pages: 1217 - 1220

16. Levodopa availability improves with progression of Parkinson’s disease

    • Dirk Woitalla
    • Oliver Goetze
    • Thomas Müller

    ORIGINAL COMMUNICATION 28 April 2006 Pages: 1221 - 1226

    

17. Paroxysmal focal dystonia with sensory symptoms secondary to cortical oligoastrocytoma

    • M.W. Koch
    • G.J. Luijckx
    • K.L. Leenders

    LETTER TO THE EDITORS 05 April 2006 Pages: 1227 - 1228

    

18. Isolated Hypoglossal nerve palsy due to amyloid cervical arthropathy in long term hemodialysis

    • Jessica Mandrioli
    • Andrea Zini
    • Alvaro Colombo

    LETTER TO THE EDITORS 11 April 2006 Pages: 1229 - 1231

    

19. Hypocretin-1 (orexin A) levels are normal in Huntington’s disease

    • Christian R. Baumann
    • Martin Hersberger
    • Claudio L. Bassetti

    LETTER TO THE EDITORS 05 April 2006 Pages: 1232 - 1233

    

20. GDAP1 mutation in autosomal recessive Charcot-Marie-Tooth with pyramidal features

    • Roberta Biancheri
    • Federico Zara
    • Carlo Minetti

    LETTER TO THE EDITORS 10 April 2006 Pages: 1234 - 1235

    

21. Pregnancy and delivery of a healthy baby in autoimmune Lambert-Eaton myasthenic syndrome

    • Christiane Schneider-Gold
    • Carsten Wessig
    • Klaus Toyka

    LETTER TO THE EDITORS 05 April 2006 Pages: 1236 - 1237

22. Leptomeningeal familial amyloidosis:

    • P. P. Urban
    • C. Hertkorn
    • K. Altland

    LETTER TO THE EDITORS 21 September 2006 Pages: 1238 - 1240

    

23. Myasthenia gravis remission and anti-AChR ab reduction after immunosuppressive and anti-neoplastic therapy in a patient with thymic Hodgkin’s disease

    • M. T. Ferrò
    • T. Riccardi
    • R. Mantegazza

    LETTER TO THE EDITORS 29 September 2006 Pages: 1241 - 1242

    

24. A 45-year history of acquired autoimmune neuromyotonia

    • Aisling Ryan
    • Gerard Mullins
    • Tim Lynch

    LETTER TO THE EDITORS 22 September 2006 Pages: 1243 - 1245

    

25. Sir Thomas Lewis MD, FRS. (1881–1945)

    • JMS Pearce

    PIONEERS IN NEUROLOGY 21 September 2006 Pages: 1246 - 1247

    

26. Have a look at eye movements

    • Michael Strupp

    JOURNAL CLUB 29 September 2006 Pages: 1248 - 1250

27. ENS COMMUNICATIONS

    • Clay E. Reilly

    OriginalPaper 20 September 2006 Pages: 1251 - 1254